INDUCE: A Prospective 2-Year Spine Registry

Enrolling by invitation

Conditions studied: Subjects Treated With NMP as Part of Their Spine Surgery, Degenerative Disc Disease (DDD)

In brief

The primary objective of this prospective, observational registry study is to evaluate the safety and effectiveness of Natural Matrix Protein® (NMP®) when used to promote fusion in the cervical or lumbar spine. The secondary objective is to assess patient reported outcomes following the use of NMP in the treatment of the spine.

Key facts

Study ID
NCT06971835
Run by
Red Rock Regeneration Inc.
People needed
1000
Starts
2026-02-17
Expected to finish
2029-01-01
Last updated by the study team
2026-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.